GGHC
GILD icon

Gilder Gagnon Howe & Co’s Gilead Sciences GILD Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25,226
Closed -$2.8M – 262
2025
Q3 		$2.8M Sell
25,226
-202
-0.8% -$23K 0.03% 179
2025
Q2 		$2.82M Sell
25,428
-11,158
-30% -$1.19M 0.03% 166
2025
Q1 		$4.1M Sell
36,586
-558
-2% -$57.6K 0.05% 144
2024
Q4 		$3.43M Buy
37,144
+17,437
+88% +$1.57M 0.04% 164
2024
Q3 		$1.65M Buy
+19,707
New +$1.5M 0.02% 191
2020
Q3 		– Sell
-17,199
Closed -$1.32M – 347
2020
Q2 		$1.32M Sell
17,199
-10,530
-38% -$807K 0.01% 229
2020
Q1 		$2.07M Buy
+27,729
New +$1.92M 0.02% 176
2017
Q2 		– Sell
-4,240
Closed -$288K – 294
2017
Q1 		$288K Sell
4,240
-17
-0.4% -$1.2K ﹤0.01% 232
2016
Q4 		$305K Hold
4,257
– – 0.01% 207
2016
Q3 		$337K Hold
4,257
– – 0.01% 216
2016
Q2 		$355K Sell
4,257
-13
-0.3% -$1.15K 0.01% 211
2016
Q1 		$392K Sell
4,270
-8
-0.2% -$721 0.01% 187
2015
Q4 		$433K Sell
4,278
-29
-0.7% -$3.02K 0.01% 196
2015
Q3 		$423K Buy
4,307
+1,548
+56% +$172K 0.01% 212
2015
Q2 		$323K Buy
2,759
+2,421
+716% +$265K ﹤0.01% 241
2015
Q1 		$33K Hold
338
– – ﹤0.01% 258
2014
Q4 		$32K Buy
+338
New +$35K ﹤0.01% 263
2014
Q2 		– Sell
-850,844
Closed -$60.3M – 312
2014
Q1 		$60.3M Sell
850,844
-173,444
-17% -$13.6M 0.82% 37
2013
Q4 		$76.9M Sell
1,024,288
-146,805
-13% -$10.2M 1.1% 29
2013
Q3 		$73.6M Sell
1,171,093
-62,864
-5% -$3.76M 1.15% 26
2013
Q2 		$63.3M Buy
+1,233,957
New +$64.3M 1.19% 28

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Gilder Gagnon Howe & Co's GILD Position: Q4 2025 in Review

Gilder Gagnon Howe & Co sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 25,226 shares — an estimated $2.8M sold.

Gilder Gagnon Howe & Co first reported a position in GILD in Q2 2013 and held it in 21 quarters. The position peaked at $76.9M in Q4 2013. 2,224 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Gilder Gagnon Howe & Co reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 25,226 Gilead Sciences shares in Q4 2025, an estimated $2.8M.
  • Gilder Gagnon Howe & Co first reported a position in Gilead Sciences in Q2 2013 and held it in 21 quarters.
  • Gilder Gagnon Howe & Co's Gilead Sciences position peaked at $76.9M in Q4 2013.
  • 2,224 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2025, filed 17 Feb 2026.